|
π
|
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
18 auth.
R. Hoyles,
R. Ellis,
Jessica Wellsbury,
B. Lees,
P. Newlands,
N. Goh,
C. Roberts,
S. Desai,
A. Herrick,
N. McHugh,
...
N. Foley,
S. Pearson,
P. Emery,
D. Veale,
C. Denton,
A. Wells,
C. Black,
R. D. du Bois
|
9 |
2006 |
9
π
|
|
π¦
|
Histologically atypical Pneumocystis carinii pneumonia.
N. Foley,
M. Griffiths,
Robert F. Miller
|
5 |
1993 |
5
π¦
|
|
π
|
SouthβWest of Englandβs Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
9 auth.
S. Barratt,
S. Mulholland,
Khaled Al Jbour,
H. Steer,
M. Gutsche,
N. Foley,
...
R. Srivastava,
C. Sharp,
H. Adamali
|
5 |
2018 |
5
π
|
|
π¬
|
Inter-relationship between tumour necrosis factor-alpha (TNF-Ξ±) and TNF soluble receptors in pulmonary sarcoidosis
L. Armstrong,
N. Foley,
A. Millar
|
5 |
1999 |
5
π¬
|
|
π
|
Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register
7 auth.
R. Mason,
N. Foley,
H. Branley,
H. Adamali,
M. Hetzel,
T. Maher,
...
J. Suntharalingam
|
4 |
2014 |
4
π
|
|
π¬
|
Pus in the thorax: management of empyema and lung abscess
J. Walters,
N. Foley,
M. Molyneux
|
3 |
2011 |
3
π¬
|
|
π’
|
Median Survival And Cause Of Death In Unselected Patients With Idiopathic Pulmonary Fibrosis In The UK
G. Mirrani,
C. Wootton,
N. Foley
|
0 |
2012 |
0
π’
|
|
π¬
|
P154βReal-world audit of patients with idiopathic inflammatory myositis-related interstitial lung disease in a European population
A. Loganathan,
S. Sturney,
N. Foley,
Tom Hartley,
S. Tansley
|
0 |
2023 |
0
π¬
|
|
π
|
Pulmonary Langerhans' cell histiocytosis (PLCH): A new UK register
7 auth.
Rebecca H. Mason,
N. Foley,
H. Branley,
Toby M. Maher,
Martin Hetzel,
H. Adamali,
...
J. Suntharalingam
|
0 |
2012 |
0
π
|
